Literature DB >> 925138

Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.

Y Harano, S Ohgaku, H Hidaka, K Haneda, R Kikkawa, Y Shigeta, H Abe.   

Abstract

Glucose, insulin and somatostatin infusion over 2 hours effectively suppressed endogenous secretion of insulin, glucagon and growth hormones. Steady state plasma glucose level (SSPG) which should be inversely proportional to insulin sensitivity was obtained. In 6 adult-onset non-obese untreated diabetics, mean value of insulin sensitivity indices was significantly reduced compared with normal. In 5 insulin-treated diabetics and in 5 subjects with borderline glucose tolerance including 2 obese subjects, insulin sensitivity for glucose utilization was also significantly diminished.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925138     DOI: 10.1210/jcem-45-5-1124

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

3.  Muscle metabolism and quality (MQI) in prediabetic sedentary man.

Authors:  J Karlsson; R Rønneberg
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

4.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

5.  Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Authors:  J P Hosker; D R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 6.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Insulin responsiveness of superficial forearm tissues in type 2 (non-insulin dependent) diabetes.

Authors:  N Kalant; D Leibovici; N Fukushima; J Kuyumjian; S Ozaki
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

8.  Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.

Authors:  K P Ratzmann; W Besch; S Witt; B Schulz
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

9.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

Authors:  R DeFronzo; D Deibert; R Hendler; P Felig; V Soman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.